FOLD

Amicus Therapeutics (FOLD)

Amicus Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:FOLD

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/10	05:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/05/09	20:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/05/09	20:00	GlobeNewswire Inc.	Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/05/08	20:00	GlobeNewswire Inc.	Amicus Therapeutics to Present at the Bank of America 2024 Health Care Conference	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/05/01	20:00	GlobeNewswire Inc.	Amicus Therapeutics to Announce First Quarter 2024 Financial Results on May 9, 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/20	20:00	GlobeNewswire Inc.	Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/12	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/07	07:22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/06	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/06	07:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/06	06:30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/05	07:35	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/02	06:39	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/02	06:33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/03/01	21:00	GlobeNewswire Inc.	Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/28	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/28	21:00	GlobeNewswire Inc.	Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/21	07:23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/21	07:21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/21	07:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/16	06:22	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/16	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/16	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/15	21:00	GlobeNewswire Inc.	Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/15	06:38	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/15	06:26	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/14	23:22	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/09	06:40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/08	21:00	GlobeNewswire Inc.	Amicus Therapeutics Receives the 2024 New Treatment Award for Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) at the 20th Annual WORLDSymposium™	NASDAQ:FOLD	Amicus Therapeutics Inc
2024/02/07	06:15	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FOLD	Amicus Therapeutics Inc